Zhu Liuying, Peng Xiaoyu, Li Hongyan, Luo Ting, Wang Jiaqi, Gao Yu, Deng Zeyuan, Li Jing, Li Wei, Zheng Liufeng, Zhang Bing
State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China.
Ausnutria Dairy (China) Co. Ltd., Changsha 410200, Hunan, China.
J Agric Food Chem. 2024 Oct 3. doi: 10.1021/acs.jafc.4c07225.
This study investigates changes in human milk oligosaccharide (HMO) composition over a 12 month breastfeeding period in rural central China. The HMO profiles of 97 mothers were analyzed by graphitized carbon liquid chromatography-electrospray ionization-mass spectrometry. This method was simple to prepare samples and can simultaneously and absolutely quantify at least 20 neutral and acidic HMOs. All mothers were classified into four milk groups based on the presence or absence of specific α-1,2 and α-1,4-fucosylated HMOs. The main oligosaccharides in milk groups I and II were 2'-FL, LDFT, LNFP-I, and LNDFH-I, while LNT, 3-FL, LNFP-II, LNFP-V, LNDFH-II, and DFLNH-b were predominant in milk groups III and IV. Additionally, the lactation period was the primary factor affecting the concentration of individual HMOs. The concentrations of most HMOs decreased with lactation and stabilized after 180 days. However, the concentrations of 3-FL, LDFT, and LNDFH II increased gradually over the lactation period, and the concentration of 3'-SL decreased during early lactation (5-180 days) but increased during later lactation (180-365 days). Furthermore, Spearman correlation analysis revealed that maternal factors and infant factors may also affect the concentration of various HMOs. These findings provide fundamental insights for the development of a comprehensive human milk database.
本研究调查了中国中部农村地区母乳喂养12个月期间人乳寡糖(HMO)成分的变化。采用石墨化碳液相色谱 - 电喷雾电离 - 质谱法分析了97位母亲的HMO谱。该方法样品制备简单,可同时对至少20种中性和酸性HMO进行绝对定量。根据特定α-1,2和α-1,4-岩藻糖基化HMO的有无,将所有母亲分为四个乳汁组。I组和II组乳汁中的主要寡糖为2'-FL、LDFT、LNFP-I和LNDFH-I,而III组和IV组乳汁中LNT、3-FL、LNFP-II、LNFP-V、LNDFH-II和DFLNH-b占主导地位。此外,哺乳期是影响个体HMO浓度的主要因素。大多数HMO的浓度随哺乳期下降,并在180天后趋于稳定。然而,3-FL、LDFT和LNDFH II的浓度在哺乳期逐渐增加,3'-SL的浓度在哺乳期早期(5 - 180天)下降,但在后期(180 - 365天)增加。此外,Spearman相关性分析表明,母亲因素和婴儿因素也可能影响各种HMO的浓度。这些发现为建立全面的人乳数据库提供了基础见解。